ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CHRS Coherus BioSciences Inc

2.01
-0.06 (-2.90%)
Last Updated: 01:34:19
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Coherus BioSciences Inc CHRS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.06 -2.90% 2.01 01:34:19
Open Price Low Price High Price Close Price Previous Close
2.05 2.01 2.0875 2.07
more quote information »

Recent News

Date Time Source Heading
25/4/202400:02GLOBECoherus Announces Presentation at the 2024 American Society..
08/4/202422:30GLOBECoherus Presents Preclinical Data for CHS-1000, a Novel..
14/3/202407:01GLOBECoherus BioSciences Reports Fourth Quarter, Full Year 2023..
06/3/202408:01GLOBECoherus to Report Fourth Quarter and Full Year 2023..
04/3/202422:22EDGAR2Form 8-K - Current report
04/3/202417:00GLOBECoherus Completes Divestiture of Ophthalmology Franchise
24/2/202409:33GLOBECoherus BioSciences Announces New Employment Inducement..
23/2/202409:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202409:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/2/202408:59EDGAR2Form 8-K - Current report
22/2/202400:30GLOBECoherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and..
06/2/202400:09EDGAR2Form 8-K - Current report
06/2/202400:00GLOBECoherus Amends Term Loan Agreement with Pharmakon Advisors,..
24/1/202412:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:01EDGAR2Form 8-K - Current report
22/1/202417:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
22/1/202417:15GLOBECoherus Announces Agreement to Divest Ophthalmology..
19/1/202408:05GLOBECoherus Presents Positive Phase 2 Clinical Data on..
10/1/202413:41EDGAR2Form 8-K - Current report
10/1/202413:39EDGAR2Form 8-K - Current report
10/1/202411:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202410:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202409:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202400:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
04/1/202408:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:00GLOBECoherus BioSciences Management to Present at the 42nd Annual..
03/1/202400:29GLOBECoherus Announces U.S. Launch of LOQTORZI™
28/12/202301:15APSAnother Biotech Massively Outperforming Broader Equities
27/12/202322:08IHMARKETNEWSWall Street Highlights: Apple Appeals Watch Ban, Tesla to..
27/12/202308:43DJNCoherus BioSciences Gets FDA OK for Udenyca Injector
27/12/202308:01GLOBECoherus Announces FDA Approval of UDENYCA ONBODY™, a Novel..
23/12/202309:00GLOBECoherus BioSciences Announces New Employment Inducement..
16/12/202308:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:13EDGAR2Form 8-K - Current report
12/12/202300:30GLOBECoherus Announces Updated NCCN Clinical Practice Guidelines..
08/12/202309:55GLOBECoherus BioSciences Announces CFO Transition Plans
08/12/202309:16EDGAR2Form 8-K - Current report
06/12/202320:00GLOBECoherus Presents Phase 1/2 Clinical Data on Casdozokitug, a..
29/11/202303:16GLOBECoherus and Junshi Biosciences Announce Publication of..
28/11/202308:03EDGAR2Form 8-K - Current report
13/11/202322:07EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202308:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:31EDGAR2Form 8-K - Current report
07/11/202308:07GLOBECoherus BioSciences Reports Third Quarter 2023 Financial..
06/11/202322:07EDGAR2Form 8-K/A - Current report: [Amend]
03/11/202323:30GLOBECoherus Presents Data from Next-generation Immuno-oncology..
03/11/202311:00GLOBECoherus BioSciences to Participate at Upcoming November..
31/10/202309:00GLOBECoherus BioSciences to Report Third Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock